Patent details

EP2853536 Title: Long-acting erythropoietin polypeptides and uses thereof

Basic Information

Publication number:
EP2853536
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP141972869
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Long-acting erythropoietin polypeptides and uses thereof
French Title of Invention:
Polypeptides d'érythropoïétine à action prolongée et leurs utilisations
German Title of Invention:
Langwirkende Erythropoietinpolypeptide und Verwendungen davon
SPC Number:

Dates

Filing date:
05/02/2007
Grant date:
03/05/2017
EP Publication Date:
01/04/2015
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
03/05/2017
EP B1 Publication Date:
03/05/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
05/02/2018
Expiration date:
05/02/2027
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
03/05/2017
 
 

Name:
OPKO Biologics Ltd.
Address:
16 Ashlegan Street, Kiryat Gat, 8211804, Israel (IL)

Inventor

1

Name:
Fima, Udi Eyal
Address:
Israel (IL)

2

Name:
Fares, Fuad
Address:
Israel (IL)

Priority

Priority Number:
764761 P
Priority Date:
03/02/2006
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/00; A61K 38/00; A61K 38/18; A61K 38/19; A61K 38/24; C07K 14/00; C07K 14/505; C07K 14/52; C07K 14/555; C07K 14/575; C07K 14/59; C07K 14/61; C12N 5/00; C12N 15/00; C12N 15/62;

Publication

European Patent Bulletin

Issue number:
201718
Publication date:
03/05/2017
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages